StockDuty ← Dashboard Nov 09, 2026 09:01 PM ET
SignalEarnings

$BBIO (BridgeBio Pharma) — 8-K: BBIO Q3 FY26: Revenue $353M (+192.6% YoY) as Net Loss Narrows to $-60M

BBIO
$78.30
+0.17%
Total revenues, net were $353.2 million, up 192.6% YoY from $120.7 million, driven by a $145.2 million increase in Attruby net product revenue and a $75.0 million BEYONTTRA sales milestone from Bayer. Net loss was $60 million, narrowing from $184.9 million a year ago, with loss from operations of just $11.6 million on the revenue ramp.
Total revenues, net were $353.2 million, up 192.6% YoY from $120.7 million, driven by a $145.2 million increase in Attruby net product revenue and a $75.0 million BEYONTTRA sales milestone from Bayer.
Sources